| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/27/2006 | US7067713 C1 Inhibitor produced in the milk of transgenic non-human mammals |
| 06/27/2006 | US7067645 useful for the visualization of protein localization and trafficking in living cells and as indicators of ectopic gene expression, thereby providing means to screen and/or select a sub-population of cells or trace cell lineage development |
| 06/27/2006 | US7067642 expression vectors; transformed cells; useful in diagnosing and treating conditions including cancer |
| 06/27/2006 | US7067636 Nucleotide sequences coding membrane protein for use as antiproliferative/antitumor/antiinflammatory/anticarcinogenic agents |
| 06/27/2006 | US7067635 For use in diagnostic methods, immunotherapy, gene therapy and as vaccines |
| 06/27/2006 | US7067634 Method for diagnosing or monitoring carbohydrate metabolism disorders |
| 06/27/2006 | US7067631 Fused DNA sequence, fused protein expressed from said fused DNA sequence and method for expressing said fused protein |
| 06/27/2006 | US7067629 Sodium channel in dorsal root ganglia |
| 06/27/2006 | US7067624 Antimicrobial proteins |
| 06/27/2006 | US7067617 Polypeptides for use in artifically controlling gene expression |
| 06/27/2006 | US7067484 AL-1 neurotrophic factor treatments |
| 06/27/2006 | US7067314 Monoclonal antibody, its immunoreactive fragment and hybridoma |
| 06/27/2006 | US7067312 PN7718 nucleic acids and use thereof |
| 06/27/2006 | US7067308 Vector for genetically modifying non-human animals |
| 06/27/2006 | US7067297 Mannosyltransferase polypeptides and polynucleotides encoding them and methods for making and using them |
| 06/27/2006 | US7067295 Glucose dehydrogenase |
| 06/27/2006 | US7067285 Desaturase genes and uses thereof |
| 06/27/2006 | US7067282 Compositions and methods using the yeast YLR110C promoter |
| 06/27/2006 | US7067281 Mammalian IAP gene family, primers, probes and detection methods |
| 06/27/2006 | US7067279 Cell culture performance with betaine |
| 06/27/2006 | US7067278 capable of hybridizing and which encodes a pigment protein capable of emitting fluorescence upon irradiation; tissue marker, fluorescent marker or general dyestuff |
| 06/27/2006 | US7067270 Method for detecting protein |
| 06/27/2006 | US7067268 immunoglobulins for neutralizing arachidonic acid metabolite releasing activity of the 19P2 ligand; used as diagnostic, prophylactic, therapeutic agents for diseases caused by abnormality in the pituitary function modulating activity (prolactin secretion promoting activity) |
| 06/27/2006 | US7067265 Transgenic cells coding membrane protein which controls intracellular hydrogen ion concentration for identifying modulators for treatment of diabetes |
| 06/27/2006 | US7067260 Detecting modulators of receptor binding activity; obtain sample containing receptor protein, incubate with modulator, monitor and evaluate protein binding |
| 06/27/2006 | US7067252 Detecting preferential gene products in sample; obtain sample, generate antibodies to gene product, obtain cell, transform with vector containing preferential gene product, incubate with antibody, detect signal from bound antibody |
| 06/27/2006 | US7067131 Methods for using anti-MUC18 antibodies |
| 06/27/2006 | US7067128 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 06/27/2006 | US7067112 Peptaibol antibiotics, synthesized from Acremonium tubakii, during fermentation and released into culture medium, containing high content of beta-aminobutyric acid and isovaline |
| 06/27/2006 | US7067109 Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids |
| 06/27/2006 | CA2124034C Gene coding for a protein regulating aureobasidin sensitivity |
| 06/22/2006 | WO2006066229A2 Elicitation of antibodies to self peptides by immunization with dendritic cells |
| 06/22/2006 | WO2006066072A2 Production of glucurono-3,6-lactone with low environmental impact |
| 06/22/2006 | WO2006066064A2 A voltage-gated, ph-sensitive anion channel and its novel splice variant involved in taste sensation |
| 06/22/2006 | WO2006065981A2 Nucleic acid molecules for optimized cab-2 expression and their use |
| 06/22/2006 | WO2006065975A2 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor |
| 06/22/2006 | WO2006065867A2 Polymer-linked pseudomonas exotoxin immunotoxin |
| 06/22/2006 | WO2006065272A2 Methods for altering acetic acid production and enhancing cell death in bacteria |
| 06/22/2006 | WO2006065166A1 Protein l1 and protein e7 peptide-based composition for treating and preventing a human papillomaviral infection |
| 06/22/2006 | WO2006064983A1 Monoclonal antibody specific human embryonic stem cell |
| 06/22/2006 | WO2006064746A1 Method of breeding cells having improved tolerance to short-chain fatty acids |
| 06/22/2006 | WO2006063783A1 Method for the deacylation of lipopeptides |
| 06/22/2006 | WO2006063533A1 Reconstitution of 5-enolpyruvylshikimate-3-phosphate synthase activity by fragment complementation |
| 06/22/2006 | WO2006063518A1 Multifunctional polypeptides |
| 06/22/2006 | WO2006063470A1 Metabolites of cyclosporin analogs |
| 06/22/2006 | WO2006063425A1 Expression vectors for treating bacterial infections |
| 06/22/2006 | WO2006002177A3 Interferon alpha receptor 1 antibodies and their uses |
| 06/22/2006 | WO2005091751A3 Novel gene associated with type 1 diabetes and methods of use |
| 06/22/2006 | WO2005089101A3 Non-pathogenic listeria vaccine vectors and methods of treatment therewith |
| 06/22/2006 | WO2005086907A3 Biosynthetic gene cluster for ambruticins |
| 06/22/2006 | WO2004071419A3 Methods and compositions for modulating glutamate transport activity in the nervous system |
| 06/22/2006 | WO2004052276A3 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/22/2006 | US20060137029 Novel G protein-coupled receptor encoding gene and diagnostic uses therefor |
| 06/22/2006 | US20060135756 Mammalian cell surface antigens; related reagents |
| 06/22/2006 | US20060135751 Human N-type calcium channel isoform and uses thereof |
| 06/22/2006 | US20060135750 Novel protein and gene encoding the same |
| 06/22/2006 | US20060135749 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 06/22/2006 | US20060135388 EGVII endoglucanase and nucleic acids encoding the same |
| 06/22/2006 | US20060134780 For producing high affinity, fully human antibodies of a desired isotype in response to immunization with any virtually any desired antigen |
| 06/22/2006 | US20060134756 Anti-IL-20 antibodies and binding partners and methods of using in inflammation |
| 06/22/2006 | US20060134755 IL-17 homologous polypeptides and therapeutic uses thereof |
| 06/22/2006 | US20060134754 IL-21 production in prokaryotic hosts |
| 06/22/2006 | US20060134753 consisting of a peptide fragment of SARS E2 spike protein, a peptide fragment of Pseudomonas exotoxin (PE) consisting of a binding domain and a translocation domain and a restriction enzyme site linker connecting the two; for inducing antibodies against SARS |
| 06/22/2006 | US20060134752 Human diacylglycerol acyltransferase 2 (DGAT2) family members and uses therefor |
| 06/22/2006 | US20060134751 Identification of novel MS4A gene family members expressed by hematopoietic cells |
| 06/22/2006 | US20060134750 Orally administering at a daily dosage of at least 1x108 Units; and continuing the administration until a desired clinical endpoint is achieved, such as a reduction in new contrast-enhanced brain lesions in multiple sclerosis patients |
| 06/22/2006 | US20060134749 Protease, DNA encoding the same, and method for manufacturing protease |
| 06/22/2006 | US20060134748 Orthogonal suppressor tRNAs and aminoacyl-tRNA synthetases and uses thereof |
| 06/22/2006 | US20060134747 Transgenic fungal strain for use as bioreactor in synthesis of glucoamylase; ethanol fermentation |
| 06/22/2006 | US20060134746 Adding photoregulated amino acids to the genetic code |
| 06/22/2006 | US20060134745 stress-related fusion proteins, antigenic peptides, and anti-stress-related antibodies; nucleic acid molecule encodes polypeptide which increases bile tolerance of cell; Lactobacillus acidophilus cell with an increased ability to survive stressful conditions compared to a wild-type |
| 06/22/2006 | US20060134744 Generating soluble human leukocyte antigens in cells from genomic DNA or cDNA, for prevention of viral, bacterial and proliferative disorders; polymerase chain reaction |
| 06/22/2006 | US20060134743 Vectors and methods for enhanced cell longevity and protein expression |
| 06/22/2006 | US20060134742 Production of GGL with low environmental impact |
| 06/22/2006 | US20060134741 Composition and methods relating to SENP1-a sentrin-specific protease |
| 06/22/2006 | US20060134740 Engineered proteases for affinity purification and processing of fusion proteins |
| 06/22/2006 | US20060134739 Synthesis of proteins by cell-free protein expression |
| 06/22/2006 | US20060134738 Gene expression inducing fusion protein and method for controlling gene expression Induction |
| 06/22/2006 | US20060134737 Ubiquitinated TNF receptor2 and its uses |
| 06/22/2006 | US20060134736 Human growth hormone conjugated with biocompatible polymer |
| 06/22/2006 | US20060134735 Preparing from cells at stationary phase in a suppressed growth condition; improved productivity of a protein and production efficiency; Escherichia coli; |
| 06/22/2006 | US20060134733 Production of functional proteins: balance of shear stress and gravity |
| 06/22/2006 | US20060134722 Method and compositions for detecting botulinum neurotoxin |
| 06/22/2006 | US20060134721 Affinity trap reactor and single-step process for purifying angiostatin-like fragment from human plasma using the same |
| 06/22/2006 | US20060134719 Novel serine protease |
| 06/22/2006 | US20060134700 Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance |
| 06/22/2006 | US20060134699 Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance |
| 06/22/2006 | US20060134686 Unary avian myeloblastosis virus reverse transcriptase and its use |
| 06/22/2006 | US20060134682 Preparation and use of superior vaccines |
| 06/22/2006 | US20060134649 Bardet-Biedl susceptibility gene and uses thereof |
| 06/22/2006 | US20060134634 Human gene |
| 06/22/2006 | US20060134619 Casein kinase i epsilon and casein kinase i delta and sleep in humans |
| 06/22/2006 | US20060134266 Enzyme |
| 06/22/2006 | US20060134128 Screening for an inhibitor of binding between human Toll-like receptor 3 and a protein of specific amino acid sequence by contacting a candidate with a transfected cell encoding the protein which expresses the receptor; increased interferon in vivo; antitumor, autoimmune agents; side effect reduction |
| 06/22/2006 | US20060134124 Immunosuppression |
| 06/22/2006 | US20060134122 Peptides of syndecan-1 for inhibition of cancer |
| 06/22/2006 | US20060134116 Ca 125 tumor antigen function and uses thereof |
| 06/22/2006 | US20060134114 Novel human kallikrein-like genes |
| 06/22/2006 | US20060134113 Preventive or therapeutic agent for sensitized T cell-mediated diseases comprising IL-6 antagonist as an active ingredient |
| 06/22/2006 | US20060134109 G protein coupled receptors and uses thereof |